“Clinical trials assessing PBM effects on diabetic neuropathy revealed pain reduction and potential quality of life improvement. Studies focusing on wound healing indicated encouraging results, with PBM enhancing angiogenesis, fibroblast proliferation, and collagen density. In glycemic control, PBM exhibits positive effects on metabolic parameters, including glucose tolerance and insulin resistance.
Clinical studies have reported PBM-induced reductions in fasting and postprandial glycemia without an increased hypoglycemic risk. This impact of PBM may be related to its effects on the beta cells and islets in the pancreas. Notwithstanding challenges, PBM emerges as a promising adjunctive therapy for managing diabetic neuropathy, wound healing, and glycemic control.”
“Wound reduction was measured at two weeks and was found to be significantly reduced in 75% of PBM treated ulcers.”
“The Early Treatment Diabetic Retinopathy Study (ETDRS) has shown the benefit of focal laser photocoagulation in decreasing the frequency of persistent macular edema and increasing the chance of visual improvement.”
“PBM emerges as a promising adjunctive therapy for managing diabetic neuropathy, wound healing, and glycemic control.”
“PBM at different wavelengths has shown positive results with regards to wound healing and fibroblast proliferation. It is also worth taking into consideration that red and NIR wavelengths have established beneficial effects in diabetic ulcer care.”
“A systematic review of four randomized clinical trials in which laser therapy was administered to patients with a diabetic foot ulcer over 2 to 16 weeks found favorable outcomes regarding ulcer size and time to healing.”